Siegfried Holding AG(0QQO)
GBP --+0.00%
Reward41Moderate
Risk37Moderate
📊75%Data
0QQO
+0.0 · +0.00%
GBP · LSE
Siegfried Holding AG |
Value Trap
Market Cap:321.05M
ℹ️
Reward Rating
41
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
37
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0QQO to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Siegfried Holding AG?

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

0QQO · Verdict

Moderate reward · moderate risk

0QQO stands out on cash flow and volatility, but watch the growth signal.

Based on 88% data coverage

0QQO · Verdict

What’s working & what to watch

Strengths 2

  • Cash flow71/100

    1% free-cash-flow margin

  • Volatility65/100

    Above average

Watchouts 2

  • Growth33/100

    Rev +2.6% CAGR · earnings +2.5%

  • Profitability35/100

    13% net margin · 16% ROE

Model-based scoring. For information only — not financial advice.

What is Siegfried Holding AG?

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company is listed on the LSE in UK, with a market capitalisation of 321.05M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (41)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap321.05M
P/E Ratio0.0354
Dividend Yield0.51%
52 Week High101.1948
52 Week Low68.3966
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding4M
No. of Employees3,891
IndustryN/A
ExchangeLSE
Beta0.786
CurrencyGBP